REVMATOID ARTRITDA DAVOLASH SAMARADORLIGINI BAHOLASHNI ZAMONAVIY MEZONLARI
DOI:
https://doi.org/10.47390/ydif-y2026v2i18/n40Kalit so‘zlar:
revmatoid artrit, DAS-28, SDAI, CDI, ACR, terapiya samaradorligi, EChT, C-reaktiv oqsil.Annotasiya
Revmatoid artrit surunkali autoimmun kasallik bo’lib, bo’g’imlarning qaytmas destruksiyasi va funksional yetishmovchiligiga olib keladi. Hozirgi zamonaviy yondashuv kasallik faolligini erta aniqlash va remissiyaga qaytarishga qaratilgan. Mazkur maqolada davolash samaradorligini baholashning DAS-28, SDAI, CDI indekslari va ACR javob mezonlari yoritiladi. Shuningdek yallig’lanish markerlari ECHT, C-reaktiv oqsil va instrumental tekshiruvlarning ahamiyati ko’rib chiqiladi hamda bemorlarning hayot sifati ko’rsatkichlarini baholash usullari ham taqdim etiladi.
Manbalar
1. Aletaha D., Neogi T., Silman A.J. et al. 2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative. *Annals of the Rheumatic Diseases*. 2010; 69: 1580–1588.
2. Firestein G.S., Budd R.C., Gabriel S.E., McInnes I.B., O’Dell J.R. *Kelley and Firestein’s Textbook of Rheumatology*. 10th ed. Philadelphia: Elsevier; 2017.
3. Prevoo M.L.L., van ’t Hof M.A., Kuper H.H. et al. Modified disease activity scores that include twenty-eight–joint counts (DAS28). *Arthritis & Rheumatism*. 1995;38:44–48.
4. Smolen J.S., Landewé R., Bijlsma J. et al. EULAR recommendations for the management of rheumatoid arthritis. *Annals of the Rheumatic Diseases*. 2020;79:685–699.
5. Smolen J.S., Aletaha D., McInnes I.B. Rheumatoid arthritis. *Lancet*. 016;388(10055):2023–2038.
6. O‘zbekiston Respublikasi Sog‘liqni saqlash vazirligi. Revmatoid artritni tashxislash va davolash bo‘yicha klinik tavsiyalar. Toshkent; 2021.
This work is licensed under a 